Wednesday, September 21, 2016

BRIEF-Gilead terminates phase 2/3 study of GS-5745 in patients with Ulcerative Colitis

* A phase 3 study of GS-5745 is ongoing in patients with

Gastric Cancer

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)